ShanX Medtech Secures €24M to Advance Ultra-Rapid AMR Diagnostics
EINDHOVEN, The Netherlands | January 7, 2026 — ShanX Medtech announced the successful close of a €24 million financing...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
EINDHOVEN, The Netherlands | January 7, 2026 — ShanX Medtech announced the successful close of a €24 million financing...
SAN FRANCISCO, December 3, 2025 — Junevity today announced the expansion of its seed funding round to $20 million...
